Sk-Nk Cell
Ascites
Cancer Institute and Hospital, Chinese Academy of Medical SciencesCell therapyPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 95/ 100
Competitive context
7 Active assets in the Ascites cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
NORMAL HUMAN SERUM ALBUMIN Centro Medico Issemym | Phase 4 | BBB |
Tolvaptan Konkuk University Medical Center | Phase 4 | BBB |
FUROSEMIDE University of Palermo | Phase 4 | BB |
Rifaximin Centre Hospitalier Universitaire de Besancon | Phase 4 | BB |
CARVEDILOL Asian Institute Of Medical Sciences | Phase 4 | BB |
View all 36 →
Same molecule, other indications
Sk-Nk Cell is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →